Evidence Review
Copyright ©The Author(s) 2025.
World J Gastrointest Pathophysiol. Jun 22, 2025; 16(2): 107265
Published online Jun 22, 2025. doi: 10.4291/wjgp.v16.i2.107265
Figure 4
Figure 4 48 months post-treatment showing disease progression (increase in 1° tumor size and secondary hepatic metastasis and nodal disease). A and B: Increased size in secondary hepatic mass (12.3 cm × 9.2 cm) at 49 months.